PTC Therapeutics, Inc. (PTCT)
75.56
+2.49
(+3.41%)
USD |
NASDAQ |
Jan 21, 16:00
75.56
0.00 (0.00%)
After-Hours: 06:59
PTC Therapeutics Market Cap: 6.067B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Spyre Therapeutics, Inc. | 2.637B |
| NovaBay Pharmaceuticals, Inc. | 740.64M |
| Palatin Technologies, Inc. | 15.16M |
| Theriva Biologics, Inc. | 6.475M |
| Oragenics, Inc. | 0.8147M |
Market Cap Related Metrics
| PE Ratio | 8.832 |
| PS Ratio | 3.492 |
| Price to Free Cash Flow | 13.92 |
| Price | 75.56 |
| Earnings Yield | 11.32% |
| Operating PE Ratio | 6.736 |
| Normalized PE Ratio | 7.646 |